Health Care

July 14, 2013

FDA approves new treatment for a type of late-stage lung cancer

The U.S. Food and Drug Administration has approved use of the drug Gilotrif for patients with a form of late stage non-small cell lung cancer.

Related content

Comments

Videos

Editor's Choice Videos